… after marrow transplantation. The reconstitution of cellular immunity against CMV was
monitored before … that helper-T-cell function is needed for the persistence of transferred CD8+ T …

… immunity or HIV patients, leukemia or transplant recipients may develop persistent anemia
… bone marrow cell appearance. The immunogenic response was very low, tested with B-19 …

… or acute infection with human parvovirus B19 can cause red … Cell-mediated immunity likely
plays an important role in viral … antibody persistence after HCT depended on prior recipient …

… for CMV antibodies or who received seropositive marrow were screened for … a treatment
for CMV pneumonia in marrow recipients. However, the combination of ganciclovir with immune …

… donor and recipient is not a barrier for successful allogeneic … This, in turn, explains persistence
of isohemagglutinins for … immune responses during the early phase after allogeneic HSC …

… viruses such as HAV or parvovirus B19, as opposed to … immune system can maintain,
even after transplantation in … clearance of persistent HBV infection, through allogenic BMT …

… a small number of adult bone marrow transplant recipients with RSV … Aerosolized antibody
has also been used for treatment of … Parvovirus B19 infects bone marrow erythroid progenitors …

… Since the lifelong persistence of B19 DNA in bone marrow, skin, … showed antibody patterns
consistent with past infection. … B19 T-cell immunity when patients assigned to a group with “…

… , and of the mechanisms underlying immune system reconstitution … Infection can persist or
recur after 3 weeks of appropriate … Parvovirus B19 is a rare cause of anemia following BMT.21, …

… recipients of T-cell-depleted allogeneic grafts, including two with monoclonal proliferations,
after infusions of unirradiated leukocytes from the marrow … detection of IgG antibody titers to …